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According to WHO data� gastric cancer �GC� occupies 
the second place �y the incidence and mortality among 
all malignant neoplasms. GC mor�idity yields ��� ��� 
cases per year� while mortality rate is close to 6������ 
per year [1].
High mortality rate largely depends on the fact that GC 
is usually revealed at the late stages �III�IV� of the disease 
[�� �]. At the same time� the results of the therapy differ in 
a wide range in the GC patients with the tumors of similar 
histology and progression stage. Due to the advances of 
modern genetics and molecular �iology� it �ecame evident 
that molecular-�iological properties of the tumor play a 
key role in the GC prognosis [4].
According to the data of a num�er of researchers 
[��1�]� distur�ed expression of the components of cell-
to-cell adhesion �cadherin-catenin complex: E-cadherin� 
α- and β-catenin� is an important event in the development 
and progression of GC. An a�sence of expression of each 
separate protein forming the complex is associated with 
unfavora�le disease course� and appearance of regional 
or distant metastases [14� 1�]. It is known also that in some 
cancers the aggressive course of the disease correlates 
with altered level of expression of growth factors stimulat-
ing angiogenesis [16]. Vascular endothelial growth factor 
�VEGF� is a key regulator of angiogenesis and induces 
proliferation of endothelium along with the formation of 
new vessels of capillary type. At the same time� apart from 
proangiogenic activity� VEGF also influences mitogenic 
�Akt� and antiapoptotic �BCL-�� proteins [17]. There is no 
common point of view in modern literature on the prog-
nostic value of expression level of the components of cell-
to-cell adhesion system and the markers of angiogenesis 
in gastric cancer.
The aim of the present research was to study the rela-
tion �etween expression of the molecules of cell-to-cell 
adhesion �E-cadherin� α- and β-catenin� and VEGF with 
traditional clinicomorphological characteristics of tumors 
to evaluate their prognostic value in GC patients.
MATERIALS AND METHODS
Retrospective study of �iological parameters of tumors 
of 1�� GC patients cured in �tate Institution “National Can-
cer Institute” Ministry of Health of Ukraine �Kyiv� Ukraine� 
in 1�������4. All patients provided an informed written 
concent to perform the study� and the present research 
was approved �y Ethic Committee of the Institute. The 
data on patients’ gender� stage of the disease� histological 
structure and differentiation grade of tumors are presented 
in Ta�le 1.
Table 1. Clinico-morphological characteristics of the patients with gastric 
cancer 
Parameters Number of samples (n)
Gender Male 89Female 61
Stage of the 
disease by TNM
II 30
III 54
IV 57
“Т”
T1 1
T2 11
T3 80
T4 58
“N”
N0 63
N1 45
N2 42
“M” M0 16M1 134
“G”
G1 2
G2 31
G3 61
G4 56
Histological type 
by Laurén [20]
Intestinal type 117
Diffuse type 33
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Aim: To study the relation between the expression of the molecules of cell-to-cell adhesion (Е-cadherin, α- and β-catenins) and 
vascular endothelial growth factor (VEGF) and traditional clinico-morphological characteristics of tumors to evaluate their prognostic 
value in the patients with gastric cancer. Methods: To analyze the expression of Е-cadherin, α- and β-catenins, and VEGF the paraffin 
embedded tumor samples were studied by immunohistochemical analysis with the use of respective monoclonal antibodies. Results: The 
presence of E-cadherin in tumors correlated with the absence of metastases in regional lymph nodes and was observed, as a rule, in 
the patients at the early stages of the disease. The presence of β-catenin expression has been detected in gastric tumors of the patients 
without distant metastases, while the level of VEGF expression correlated with the degree of gastric wall injury. It has been demonstrated 
that the expression of E-cadherin and α-catenin is associated with favourable disease course and is a characteristic pattern for early 
stages of gastric cancer of intestinal type. However, VEGF expression is typical for the late stages of gastric cancer of diffuse type 
and is associated with poor prognosis. Conclusion: At the base of combined clinical, histological and immunohistochemical analysis of 
gastric tumors it has been shown that E-cadherin, α-catenin and VEGF could be used as informative markers of the disease course.
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For detection of the E-cadherin� α- and β-catenins� 
VEGF proteins respective monoclonal anti�odies were 
used �respectively clones NCH-��� α-catenin-1� 
β-catenin-1 and VG1� Dako Cytomation� Denmark�. 
For visualization of immunohistochemical reaction� 
Envision+ kit and ���-diamino�enzidine �Dako Cyto-
mation� Denmark� were used� with the next staining of 
slides with hematoxiline.
The tumors were considered positive �y studied 
marker if cytoplasmic reaction was present in > ��% 
cells.
�tatistical analysis of the data was performed with 
the use of program �TATI�TICA 6.�. Correlation analy-
sis was done using Pearson association coefficient for 
patterns that had � grades �the presence of distant 
metastases and metastases in regional lymph nodes� 
histological type of tumor�. For patterns that had more 
than � gradations �the degree of gastric wall injury and 
metastases in regional lymph nodes� stage of the dis-
ease �y TNM classification� survival time�� Chuprov’s 
coefficient of reciprocal contingency �К� was used. 
�ignificancy of mentioned coefficients was evaluated 
�y χ� criterium [1�]. Patient’s survival was analyzed �y 
Kaplan-Mayer’s test. Comparison of survival curves 
was performed with the use of Log-rank-test. 
RESULTS AND DIScUSSION
Relation between expression of markers of 
cell-to-cell adhesion and angiogenesis and GC 
stage. It is known that the stage of gastric tumors 
�y TNM classification is an important prognostic pat-
tern influencing the course of the disease. As a rule� 
characteristics of the primary lesion �Т� indicates the 
timeliness of GC diagnosis and allows prescri�e an ad-
equate therapy [1�]. Upon the study of E-cadherin ex-
pression� we have shown an o�vious relation �etween 
its presence in tumor and GC mor�idity �Ta�le ��. The 
highest expression level of the protein was o�served 
in 7�.�% tumor samples of the patients with II stage 
�Fig. 1� a�� and is �y ��.�7% higher �р < �.���� than that 
in the patients with III stage and �y 4�.47% higher �p < 
�.��� than in the patients with stage IV. By our data ex-
pression of α-catenin was o�served in �1.7�% samples 
of the patients with stage II �Fig. 1� b�� and is �y ��.�4% 
higher �р < �.��� than that in the patients with stage 
III and �y �1.�% higher �р < �.��� than that in the pa-
tients with stage IV. The percent of β-catenin-positive 
tumors has �een decreasing progressively dependent 
on the stage of the disease and was �7.��%� �7.7�% 
and �4.�6% in the patients of stages II �Fig. 1� c�� III 
and IV respectively. Expression of VEGF in the studied 
samples was o�served as a rule mainly at the late 
stages �71.��% at stage IV versus �4.14% at stage II 
�Fig. 1� d�� and ��.6�% at stage III respectively�.
Table 2. Correlation between expression of GC molecular markers 
and the stage of the disease progression (by TNM classification)
Marker Tumors positive for studied marker, % K pStage II Stage III Stage IV
E-cadherin 79.31 40.74 36.84 0.29 < 0.01
α-Catenin 51.72 31.48 29.82 0.15 > 0.05
β-Catenin 37.93 27.78 24.5 0.08 > 0.05
VEGF 24.14 29.63 71.93 0.34 < 0.05
a b
c d
e f
fig. 1. Immunohistochemaical analysis of VEGF� E-cadherin� 
α- and β-catenin expression� x ���. a� E-cadherin expression in 
stage II gastric cancer tissue samples; b� α-catenin expression 
in stage II gastric cancer tissue samples; c� β-catenin expression 
in stage II gastric cancer tissue samples; d� VEGF expression in 
stage II gastric cancer tissue samples; e� β-catenin expression in 
samples with metastases in lymph nodes �N��; f� VEGF expression 
in samples with high degree of gastric wall injury �T4�
�o� we have o�served the change of the percent of 
tumors positive �y the studied markers of cell-to-cell 
adhesion and angiogenesis� dependent on the stage 
of the disease �y TNM classification.
To determine the nature of such changes� we have 
performed a study of contingency of the relations �et-
ween the presence of these proteins in gastric tumors 
and the main characteristics used in TNM classification� 
namely� the degree of gastric wall injury� the presence 
of metastasis in lymph nodes� and distant metastases. 
The results of correlation analysis have demonstrated 
the existence of an o�vious dependence �etween 
the presence of expression of markers of cell-to-cell 
adhesion and angiogenesis in gastric tumor cells and 
the degree of lymph node metastasis �Fig. ��. The 
presence of E-cadherin in GC samples correlates with 
the a�sence of metastases in regional lymph nodes 
�N��. In particular� 74.6% cases without metastases in 
lymph nodes were E-cadherin-positive� while in N1 and 
N� cases the level of expression decreased to �6.67% 
and 16.67%� respectively �Fig. �� b�. High content of 
α-catenin-positive cells was o�served in tumor samples 
from the cases without metastases in regional lymph 
nodes �61.�� %�� and was �.6 fold higher and �.�4 fold 
higher than that in N1 and N� cases respectively.
Also we have revealed a tendency for decrease of 
the percent of β-catenin-positive tumors in the pa-
tients with high degree of lymph node metastasis �N�� 
�Fig. 1�  e�� compared to that index in the patients with 
lymph node status N1 and N� �16.67% vs �1.11%� and 
�4.��%� respectively �Fig. �� b�. Along with this� it was 
shown that β-catenin is present in the cases without 
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distant metastases �4�.7�%�� while in the cases with 
distant metastases its expression was �y 1�.��% 
lower. Exp ression of VEGF was mainly o�served in the 
GC cases with high degree of gastric wall injury �Fig. 1� 
f� �6�.�7% positive tumors of Т4 stage vs �7.�7% and 
��.��% positive tumors at Т� and Т� stages respectively� 
�Fig. �� a�� and also in the cases with metastasis in re-
gional lymph nodes ���.��% in N1 cases and ��.��% 
N� cases vs �4.��% for the patients without metastases 
in regional lymph nodes� �Fig. �� b�.
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fig. 2. Distri�ution of the tumors positive for the studied mar-
kers� dependent on the degree of gastric wall injury �a� and 
lymph nodes status �b�
Using calculation of Chuprov’s coefficient of re-
ciprocal contingency �К�� we have reveal correlation 
�etween the stage of the disease �y TNM classification 
and the presence of E-cadherin �К = �.�1� and VEGF 
�К = �.�4� in tumors. Also� the presence of E-cadherin 
�К = �.4��� α-catenin �К = �.41� and VEGF �К = �.14� 
in tumors correlates with the degree of lymph node 
metastasis.The presence of VEGF correlates also with 
the degree of gastric wall injury �К = �.���. 
Relation between expression of cell-to-cell 
adhesion markers and angiogenesis and his-
tological type of GC. It is known that histological 
analysis is a key diagnostic method for malignant 
neoplasia including GC and allows determine a num�er 
of important clinico-morphological patterns. Pres-
ently� histological classification of GC �y Laurén [��] 
is widely used in clinical practice; it classifies two types 
of gastric cancer differing in their clinical course and 
morphogene sis - intestinal and diffuse ones [�1].
According to our results �Ta�le ��� intestinal and 
diffuse GC types differ also �y the presence of expres-
sion of studied markers. In particular� in intestinal type 
expression of E-cadherin and β-catenin was detected 
�.�- and �.4-fold more often. α-catenin expression 
was present in tumors of intestinal type ��1.6�%�� as 
well as diffuse type �4�.4�%� without statistical sig-
nificance. According to our data� hyperexpression of 
VEGF was o�served mainly in tumors of diffuse type 
�6�.64%�� in accordance with the data of literature [17� 
��] that descri�e diffuse type of GC as aggressive one 
and with early metastasis. �o� we have demonstrated 
that there is a dependence �etween the presence of 
studied markers and histological type of GC.
Table 3. Correlation between expression of GC molecular markers 
and histological type of tumors by Laurén classification [20]
Marker Tumors positive for studied marker, % rА pIntestinal type Diffuse type
E-cadherin 78.79 34.19 0.36 < 0.01
α-Catenin 31.62 42.42 0.08 < 0.01
β-Catenin 63.64 18.80 0.39 < 0.01
VEGF 39.32 63.64 0.19 < 0.01
Prognostic value of adhesion and angiogenesis 
markers as indexes of survival time of GC patients. 
The samples of gastric tumors were distri�uted to three 
groups dependent on survival time of the patients: 
1� survival time < 1 year �n = 77�; �� survival time = 
1�� years �n = 4�� �� survival time > � years �n = ���. 
Distri�ution of the studied samples positive �y studied 
markers dependent on survival time of the patients are 
shown in Ta�le 4.
Table 4. Correlation between expression of GC molecular markers 
and survival of GC patients
Marker Tumors positive for studied marker, % K pGroup 11 Group 22 Group 33
E-cadherin 16.88 66.67 82.14 0.48 < 0.01
α-Catenin 19.48 31.11 78.57 0.39 < 0.01
β-Catenin 33.77 24.44 21.43 0.10 > 0.05
VEGF 64.94 24.44 21.43 0.35 < 0.01
Notes:  1survival t ime < 1 year; 2survival t ime = 1–3 years; 
3survival time > 3 years.
We have shown that in the majority of tumors of the 
patients from group 1 hyperexpression of VEGF and an 
a�sence of E-cadherin and α-catenin was o�served. In 
group � increase of the percent of E-cadherin-positive 
tumors �66.67%� and α-catenin-positive ones ��1.11%� 
was detected as well as the decrease of the percent of 
VEGF-positive tumors ��4.44%� compared to group 1. 
Characteristic pattern of tumors of group � was elevated 
expression of E-cadherin ���.14% cases� and α-catenin 
�7�.�7% cases� and low level of VEGF expression 
���1�%� only in the �1.4�% cases. β-catenin expression 
was o�served in tumors of the patients from all three 
groups with the tendency for decrease of β-catenin-
positive tumors in group � compared to group 1 ��1.�4% 
and ��.77%� respectively�. 
Analysis of survival curves �y the method of Kap-
lan — Mayer �Fig. ��. has shown that survival of GC 
patients was significantly higher in the cases of expres-
sion of E-cadherin and а-catenins and in the a�sence 
of VEGF expression. 
At the �ase of the results of correlation and com-
parative analisis of survival curves we have demon-
strated that the presence of E-cadherin and α-catenin 
in gastric tumors as well as the a�sence of VEGF could 
�e considered as the markers of favora�le prognosis 
�y criterium of survival time. 
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fig. 3. Kaplan — Mayer distri�ution of the patients �y survival 
time dependent on the presence of E-cadherin �a�; α-catenin 
�b�; β-catenin �c� and VEGF �d� in tumor cells
In conclusion� the relation �etween expression 
of cell-to-cell adhesion molecules �E-cadherin� α-� 
β-catenins� and VEGF and traditional clinico-morpho-
logical characteristics of tumors and survival time of 
GC patients has �een revealed. We have shown the 
existence of correlation �etween the presence of 
expression of markers of cell-to-cell adhesion and 
angiogenesis and the stage of the disease. It is de-
monstrated that the presence of E-cadherin in gastric 
tumors correlates with the a�sence of metastases 
in regional lymph nodes and is o�served as a rule at 
early stages of the disease. the presence of β-catenin 
expression is characteristic for GC tumors without 
distant metastases� while the level of VEGF expression 
correlates with the degree of gastric wall injury. Along 
with this� the presence of E-cadherin and α-catenin 
expression in GC is associate with favora�le progno-
sis and is o�served in patients with intestinal type of 
gastric tumors at early stages of the disease. Contrary� 
VEGF is a marker of unfavora�le disease course and 
its expression is characteristic for diffuse type of GC at 
late stages of the disease and shorter survival. 
�o� at the �ase of com�ined clinical� histological 
and immunohistochemical analysis of gastric tumors 
it has �een shown that E-cadherin� α-catenin and 
VEGF could �e used as informative markers of the 
disease course.
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КОРРЕЛЯЦИЯ МЕЖДУ МЕЖКЛЕТОЧНОЙ АДГЕЗИЕЙ, 
АНГИОГЕНЕЗОМ И КЛИНИКО-МОРФОЛОГИЧЕСКИМИ 
ПРОГНОСТИЧЕСКИМИ ФАКТОРАМИ БОЛЬНЫХ РАКОМ ЖЕЛУДКА
Цель: изучение связи экспрессии молекул межклеточной адгезии (Е-кадгерина, α- и β-катенина) и фактора роста 
эндотелия сосудов (VEGF) с традиционными клинико-морфологическими характеристиками опухолей для определения 
их прогностического значения у больных раком желудка. Методы: для определения данных белков в парафиновых 
срезах тканей пациентов использовали иммуногистохимический метод с использованием моноклональных антител, 
специфических к Е-кадгерину, α- и β-катенину, а также VEGF. Результаты: присутствие в карциномах Е-кадгерина 
коррелировало с отсутствием метастазов в регионарных лимфатичнеских узлах и наблюдалось, как правило, у больных 
на ранних стадиях болезни. Наличие экспрессии β-катенина отмечалось в карциномах желудка тех больных, которые не 
имели отдаленных метастазов, а уровень экспрессии VEGF четко коррелировал со степенью поражения стенки желудка. 
Показано, что экспрессия Е-кадгерина и α-катенина ассоциируется с благоприятным прогнозом и является характерным 
признаком ранних стадий рака желудка кишечного типа. В то же время экспрессия VEGF характерна для поздних стадий 
рака желудка диффузного типа и указывает на неблагоприятный прогноз. Выводы: в результате комплексного клинического, 
гистологического и иммуногистохимического анализа рака желудка установлено, что определение Е-кадгерина, α-катенина 
и VEGF может быть использовано в качестве информативных маркеров течения заболевания.
Ключевые слова: рак желудка, прогноз, E-кадгерин, α-катенин, β-катенин, VEGF.
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